esc
Search documents
go
Browse entities
go
Corpus stats
go
About the data
go
AI settings
go
EFTA
Search
Search
Entities
About
Stats
Settings
⌘K
search
Search
Search syntax help
Dataset
Set 1
Set 2
Set 3
Set 4
Set 5
Set 6
Set 7
Set 8
Set 9
Set 10
Set 11
Set 12
Sort
Relevance
Most pages
Most words
Dataset
Newest
Oldest
Status
All
Extracted
Failed
DOJ Status
All
Removed
Available
Modified
Date Range
Undated only
–
Email Headers
Page Count
–
Saved Searches
+
190 results for “
"Ariad"
”
Export
Keyboard Shortcuts
/
Focus search
Esc
Blur input
O
Open PDF
←
→
Paginate
Corpus: 1990-03-17 – 2025-12-01
←
October 2013
→
Mo
Tu
We
Th
Fr
Sa
Su
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Undated
(150,429)
None
Light
Medium
Heavy
EFTA02708253
Dataset 11
2013-10-09
1p
91w
Subject:
Ariad
From:
Harry Beller
To:
Jeffrey Epstein
…To: Jeffrey Epstein Subject:
Ariad
Attachments: SKMBT_C25313100913160.pdf, Untitled attachment 00458.txt Jeffrey Southern Financial has a position of 16,535 shares of
Ariad
=harmaceuticals (ARIA)with a cost basis of 17.59 per share. Today the stock is plunging as a result of a cancer drug side effect =see attached). This position is currently at JPM and is in the process of the ACAT to =B I called Stacey at JPM to ask Paul Barrett to get in…
https://www.justice.gov/epstein/files/DataSet%2011/EFTA02708253.pdf
EFTA01121561
Dataset 9
2013-04-23
13p
9,237w
…643) 18-Jan-13 NCLH 1,600 Norwegian Cruise Line Holdin USD Consumer, Cyclical 0.00% ($30,400) $39,328 18..lan.13 19.00 24.58 $8.928 18-Jan-13 NTI 5,200 Northern Tier Energy Lp USD Energy 19.02% (5127,192) $126,149 18..lan.13 24.46 24.26 (51.043) 14-Feb-13 ARIA 9,000
Ariad
Pharmaceuticals Inc USD 'name,. Nowt-cyclic 0.00% (S136.878) 5174,408 24..lan.13 15.21…
https://www.justice.gov/epstein/files/DataSet%209/EFTA01121561.pdf
EFTA01121574
Dataset 9
2013-04-30
14p
9,342w
…00 18.56 (52,643) 18-Jan-13 NCLH 1,600 Norwegian Cruise Line 14oldin USD Consumer, Cyclical 0.00% 1530,400) 139,328 18-lan-13 19.00 2938 $8,928 18-Jan-13 Nn 5.200 Northern Tier Energy Lp USD Energy 1926% (S122,192) 5126,149 18-lan-13 24.46 29.26 (51,043) 14-Feb-13 ARIA 9,000
Ariad
Pharmaceuticals Inc USD snsunwr, Non-cyclic 0.00% (1134878) $174,408 24-Jan-13 1521 …
https://www.justice.gov/epstein/files/DataSet%209/EFTA01121574.pdf
EFTA01465999
Dataset 10
2013-12-23
19p
4,004w
…recommercialization of Iclusig with a narrower label, and we consider the REMS accompanied by four PMRs without an Elements to Assure Safe Use (ETASU) to be a favorable. We discuss the new label, REMS, and PMRs in detail herein. We are upgrading
Ariad
shares to Outperform and increasing our price target from $3 to $12 (exhibit 1, on page 5), based on the following: 1) limited downside with REMS and PMRs in place, in our opinion; 2) positive physician feedback…
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01465999.pdf
EFTA01450727
Dataset 10
2013-12-23
1p
733w
…Use (ETASU) to be a FY P/E NM NM NM favorable. We discuss the new label, REMS, and PMRs in detail herein. CY P/E NM NM We are upgrading
Ariad
shares to Outperform and increasing our price target from Trading Data (FactSet) $3 to $12 (exhibit 1, on page 5), based on the following: 1) limited downside with Shares Outstanding (mil.) 185 REMS and PMRs in place, in our opinion; 2) positive physician feedback during ASH Moat (mil.) …
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01450727.pdf
EFTA01447255
Dataset 10
2014-04-02
1p
140w
Subject:
Biotech Update... [C]
…[C] Classification: confidential Jeffrey - Biotech forming a base to some extent (strong market backdrop, clearly) - you're up 5906k on your basket excluding the
Ariad
(outlier due to 4&A prospects vs. group drivers) 1-mo price history charts below. (Embedded image moved to file: pic08428.gif) SGMO lmo Price History (Embedded image moved to file: pic07767.gif) BII8 lmo Price History (Embedded image moved to file: pic25070.gif) GILD lmo Price History (Embedded image moved to file: pic18644.gif…
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01447255.pdf
EFTA01461547
Dataset 10
2014-04-16
1p
266w
Subject:
Re: Biotech Update... note bounce in Foundation Medine on withdrawal of prior secondary offering ICI
From:
Tazia Smith
To:
jeevacation@gmailcom
…really bounced off it's recent lows of 4-424 (chart below); yesterday the company withdrew a prior filing for a 4150mm secondary offering. we break out
Ariad
because it is more m&A driven at this point than sector beta. (Embedded image moved to file: pic12075.gif) (Embedded image moved to file: pic19160.gif) From: Tazi a smi th/db/dbcom To:
[email protected]
, Cc: Paul Morris, vahe stepanian/db/dbcom@DBAmeri cas, Nay Dupta/db/dbcom@DBEMEA…
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01461547.pdf
EFTA01452690
Dataset 10
2013-10-28
1p
305w
…037833100 10/28/13 2,000.000 529.0600 1,058,120.50 500.8000 1.001.200.00 -56.920 50 24,400 00 2.43%
ARIAD
PHARMACEUTICALS INC Security Identifier: ARIA Dividend Option:Cash CUSP 04033A100 02114112'.13 7,535.000 15.2090 114,597.40 7.3900 55,683.65 -58,913.75 01/24/13 %II 9,000.000 19.6000 176,400.00 7.3900 66,510.00 -109.890.00 Total Nonosvered 16,535…
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01452690.pdf
EFTA01452807
Dataset 10
1p
160w
…1.00 Endo Health (ENDP) $ 1.00 5 1.00 5 1.00 HCA Holdings (MCA) 5 0.50 $ 1.00 $ 1.00 Rite Aid 'RAD) $ 0.50 5 0.50 5 0.50 Foundation Medical [FMI) 5 0.70 5 0.70
Ariad
[ARIA) 5 0.10 $ 0.10 Sangamo Biosciences (56M0 5 1.00 $ 1.00 Biogen IBIlB) 5 0.50 $ 0.60 $ 1.10 Agerion [AEGR) 5 0.50 …
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01452807.pdf
EFTA01470825
Dataset 10
2004-06-01
8p
861w
…01/30/03 N/C BANK AMER CORP PERP NON COMULATIVE DEP SHS FIXED TO FLOAT 8.125% 04/30/58 B/- E DTD 04/30/08 CLB CLB 05/15/18 @100.000 ASCENA RETAIL GROUP INC COM
ARIAD
PHARMACEUTICALS INC APOLLO GLOBAL MGMT LLC CL A SHS ALLY FINL INC FIX TO FLT DIV-8.50% FREQ-QTRLY CALLABLE @ 25.00 ON A QTRLY BASIS AFTER 05/15/2016 GMAC CAP TR I GTD TR PFD SECS SER…
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01470825.pdf
EFTA01479567
Dataset 10
2014-04-16
2p
215w
Subject:
Re: Biotech Update... note bounce in Foundation Medine on
From:
Tazia Smith sz: >
To:
[email protected]
…filing for a $150mm secondary offering. We break out
Ariad
because it is more M&A driven at this point than sector beta. From: Taz • jeevacati Paul Morris, Vahe Stepanian Nav Gupta Vinit Sahni/db/- Date: 04/02/2014 03:42 PM Subject: Biotech Update... [C] Classification: Confidential Jeffrey - Biotech forming a base to some extent (strong market backdrop, clearly) - you're up $906k on your basket excluding the
Ariad
(outlier due to M&A prospects vs. group drivers) 1…
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01479567.pdf
EFTA01492655
Dataset 10
2011-12-01
1p
266w
…19 J.P. MORGAN SECURITIES LLC (ID: 570759-10-0) 12/15 Purchase MICHAEL KORS HOLDINGS LTD G 20.00 J.P. MORGAN 7,500.000 20.00 (150,000.00) 12/20 SECURITIES LLC (ID: 060754-10-1) 12/15 Purchase
ARIAD
PHARMACEUTICALS INC C 10.42 J.P. MORGAN 4,500.000 10.42 (46,890.00) 12/20 SECURITIES LLC (ID: 04033A-100) 12/15 Purchase LAREDO PETROLEUM HOLDINGS IN C 17,00 J.P. 3,600…
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01492655.pdf
EFTA01450731
Dataset 10
2013-09-30
1p
472w
William Blair & Company, L LC. MPORTANT DISCLOSURES William Blair is a market maker in the security of
ARIAD
Pharmaceuticals, Inc. and may have a long or short position. William Blair Intends to seek investment banking compensation in the next three months from the subject company covered in this report. Additional information is available upon request. This report is available in electronic form to registered users via Ft*Docs's at wivivxdoa.com or www.williamblair.com. Please contact us at…
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01450731.pdf
EFTA01479577
Dataset 10
2014-04-22
2p
206w
Subject:
Re: Biotech Update... Gilead beat, shares halted [C]
From:
Tazia Smith < E>
To:
[email protected]
…Biotech Update... [C] Classification: Confidential Jeffrey - Biotech forming a base to some extent (strong market backdrop, clearly) you're up $906k on your basket excluding the
Ariad
(outlier due to M&A prospects vs. group drivers) 1-mo price history charts below. EFTA01479577 SGMO lmo Price History BIIB lmo Price History GILD lmo Price History FMI lmo Price History Tazia Smith Director I Key Client Partners - US DB Securities Inc Deutsche Asset & Wealth Management 345 Park Avenue, 10154-0004 New…
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01479577.pdf
EFTA01461625
Dataset 10
2014-04-02
1p
155w
Subject:
Biotech Update... [C]
…[C] classification: confidential Jeffrey - Biotech forming a base to some extent (strong market backdrop, clearly) you're up S906k on your basket excluding the
Ariad
(outlier due to m&A prospects vs. group drivers) 1-mo price history charts below. (Embedded image moved to file: pic06061.gif) SGMO lmo Price History (Embedded image moved to file: pic03646.gif) BIIB lmo Price History (Embedded image moved to file: pic17133.gif) GILD 1mo Price History (Embedded image moved to file: pic19498.gif…
https://www.justice.gov/epstein/files/DataSet%2010/EFTA01461625.pdf
EFTA00599823
Dataset 9
2013-04-23
13p
9,237w
…643) 18-Jan-13 NCLH 1,600 Norwegian Cruise Line Holdin USD Consumer, Cyclical 0.00% ($30,400) $39,328 18..lan.13 19.00 24.58 $8.928 18-Jan-13 NTI 5,200 Northern Tier Energy Lp USD Energy 19.02% (5127,192) $126,149 18..lan.13 24.46 24.26 (51.043) 14-Feb-13 ARIA 9,000
Ariad
Pharmaceuticals Inc USD 'name,. Nowt-cyclic 0.00% (S136.878) 5174,408 24..lan.13 15.21…
https://www.justice.gov/epstein/files/DataSet%209/EFTA00599823.pdf
EFTA01121630
Dataset 9
2013-11-22
15p
10,820w
…56 (52.643) I8-Jan-13 1.600 Norwegian Cruise Line Holdin USD Consumer, Cyclical 0.00% (530,400) $39.328 18-Jan-13 19.00 24.58 $8,928 I8-Jan-13 Nfl 5,200 Northern Ter Energy Lp USD Energy 2048% (5127.192/ $126,149 18-Jan-13 24.46 24.26 (51,043) 14-Feb-I3 ARIA 9,000
Ariad
Pharmaceuticals Inc USD 'mower, Non-cyclic 0.00% ($136.878) $174408 24-Jan-13 15.21 19…
https://www.justice.gov/epstein/files/DataSet%209/EFTA01121630.pdf
EFTA01118832
Dataset 9
2012-09-30
25p
8,895w
…During July 2011 we withdrew $ $2,478,520 On 2/14/12 the account was reduced by $501.930 for the purchase of 16.535
Ariad
Pharmaceuticals 8 2095 Biogen IDEC on 5122112 the account was reduced by 11,330.000 for the purchase of 35.000 shares of Faceboot In August 2012 the account received 5349.402 from the sales proceeds od 17.500 sh of Facebook On 9/12/12 the account was reduced by S10mm for…
https://www.justice.gov/epstein/files/DataSet%209/EFTA01118832.pdf
EFTA01144207
Dataset 9
2013-11-22
14p
8,791w
… Consumer, Cyclical 0.00% ($30.400) $39,328 18-Jan-13 19.00 24.58 $8.928 18-lan-13 NTI 5200 Northern Tier Energy Lp Energy 17.00% ($127,192) $126,149 18-Jan-13 24.46 24.26 ($1.043) 14-Feb.13 ARIA 9,000
Ariad
Pharmaceuticals Inc winner, Non-cyclic 0.00% ($136,878) $174,408 24-Jan-13 1521 19.38 137,530 24-lan-13 BPL 4,000 Buckeye Partners Lp Energy 6.79…
https://www.justice.gov/epstein/files/DataSet%209/EFTA01144207.pdf
EFTA01121588
Dataset 9
2013-05-31
14p
10,128w
…USDARS 52846 USDKRW 1129.64 EURUSD 12994 USOORL 2.1322 USOOIF 0.9547 USDCAD 1.0368 USDTRY 1.874 USONOX SA716 • Untied via Bloornbe Symbol Dividend Entry Price Current Price Trade Date Shares Company Currency Industry Cost Basis (S) Market Value IS/ MTh, Yield (Local) (Local) 24 /an-13 ARIA 9,000
Ariad
Pharmaceuticals Inc msurner, Non-cyclic 0.00% ($176,400) $165,060 19.60 1834 ($11,340) 14-Feb-12 ARIA 7,535
Ariad
Pharmaceuticals Inc USD snsurner…
https://www.justice.gov/epstein/files/DataSet%209/EFTA01121588.pdf
1–20 of 190 results · page 1 of 10
«
←
1
2
…
10
→
»
Results by Dataset
190 total
Set 8
1
Set 9
31
Set 10
156
Set 11
2